ATE363070T1 - Auswertung von biologischen mitteln in lebenden zielzellen - Google Patents
Auswertung von biologischen mitteln in lebenden zielzellenInfo
- Publication number
- ATE363070T1 ATE363070T1 AT00985423T AT00985423T ATE363070T1 AT E363070 T1 ATE363070 T1 AT E363070T1 AT 00985423 T AT00985423 T AT 00985423T AT 00985423 T AT00985423 T AT 00985423T AT E363070 T1 ATE363070 T1 AT E363070T1
- Authority
- AT
- Austria
- Prior art keywords
- target cells
- biological agents
- evaluation
- living target
- living
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9915884A FR2802645B1 (fr) | 1999-12-16 | 1999-12-16 | Methode d'evaluation de la performance d'un ensemble d'agents biologiques dans des cellules cibles vivantes et ses applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE363070T1 true ATE363070T1 (de) | 2007-06-15 |
Family
ID=9553337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00985423T ATE363070T1 (de) | 1999-12-16 | 2000-12-13 | Auswertung von biologischen mitteln in lebenden zielzellen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030129584A1 (de) |
| EP (1) | EP1244912B1 (de) |
| AT (1) | ATE363070T1 (de) |
| DE (1) | DE60034966D1 (de) |
| FR (1) | FR2802645B1 (de) |
| WO (1) | WO2001044809A2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2808804B1 (fr) * | 2000-05-09 | 2002-08-02 | Nautilus Biotech | Procede de determination du titre d'agents biologiques en temps reel dans des cellules cibles vivantes et ses applications |
| US20030129203A1 (en) * | 2001-08-27 | 2003-07-10 | Nautilus Biotech S.A. | Mutant recombinant adeno-associated viruses |
| US7647184B2 (en) * | 2001-08-27 | 2010-01-12 | Hanall Pharmaceuticals, Co. Ltd | High throughput directed evolution by rational mutagenesis |
| US20050202438A1 (en) * | 2002-09-09 | 2005-09-15 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| ATE466085T1 (de) * | 2002-09-09 | 2010-05-15 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
| US20060020396A1 (en) * | 2002-09-09 | 2006-01-26 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| US7998930B2 (en) | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
| KR20080019606A (ko) * | 2005-05-04 | 2008-03-04 | 나우틸루스 바이오텍 | 변형된 인터페론-감마 폴리펩티드 및 변형된 인터페론-감마폴리펩티드를 사용하는 방법 |
| WO2007110231A2 (en) * | 2006-03-28 | 2007-10-04 | Nautilus Biotech, S.A. | MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES |
| EP2423307A1 (de) | 2006-06-19 | 2012-02-29 | Catalyst Biosciences, Inc. | Modifizierte Gerinnungsfaktor-IV-Polypeptide und deren Verwendung bei der Behandlung |
| EP2120998B1 (de) | 2006-11-28 | 2013-08-07 | HanAll Biopharma Co., Ltd. | Modifizierte erythropoetin-polypeptide und ihre verwendungen zur behandlung |
| US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
| US10943676B2 (en) | 2010-06-08 | 2021-03-09 | Cerner Innovation, Inc. | Healthcare information technology system for predicting or preventing readmissions |
| GB201411060D0 (en) * | 2014-06-20 | 2014-08-06 | Oncimmune Ltd | Improved immunoassay method |
-
1999
- 1999-12-16 FR FR9915884A patent/FR2802645B1/fr not_active Expired - Fee Related
-
2000
- 2000-12-13 AT AT00985423T patent/ATE363070T1/de not_active IP Right Cessation
- 2000-12-13 DE DE60034966T patent/DE60034966D1/de not_active Expired - Lifetime
- 2000-12-13 US US10/168,075 patent/US20030129584A1/en not_active Abandoned
- 2000-12-13 EP EP00985423A patent/EP1244912B1/de not_active Expired - Lifetime
- 2000-12-13 WO PCT/FR2000/003503 patent/WO2001044809A2/fr active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1244912B1 (de) | 2007-05-23 |
| WO2001044809A2 (fr) | 2001-06-21 |
| FR2802645B1 (fr) | 2002-03-08 |
| US20030129584A1 (en) | 2003-07-10 |
| FR2802645A1 (fr) | 2001-06-22 |
| WO2001044809A3 (fr) | 2001-12-20 |
| DE60034966D1 (de) | 2007-07-05 |
| EP1244912A2 (de) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR19C1020I1 (fr) | Nouvelles molecules b7-4 et leurs utilisations | |
| DK2316852T3 (da) | Stabiliserede enkeltdomæne-antistoffer | |
| DE60034966D1 (de) | Auswertung von biologischen mitteln in lebenden zielzellen | |
| ATE397752T1 (de) | Verfahren und verwendung von anordungen von proteinfixierungsmitteln | |
| ATE549347T1 (de) | Gene von säugetiere, und damit verbundene reagentien, methoden | |
| WO2004041865A3 (en) | Stabilized single domain antibodies | |
| ATE476654T1 (de) | Plattform für protein-profiling | |
| CY1111006T1 (el) | Εκριμματαση ασθενειας alzheimer | |
| HUP0200400A2 (hu) | Fehérjék izolálása és elemzése | |
| DE69813158D1 (de) | Assays zur Bestimmung von Proteinfragmenten in biologischen Medien | |
| DK0961780T3 (da) | Proteinmarkörer for lungecancer og anvendelse deraf | |
| DK0692025T3 (da) | Gærceller, der er konstrueret således, at de producerer surrogater for proteiner i feromonsystemet, og anvendelser deraf | |
| ATE311443T1 (de) | Methoden zur durchforstung (screenen) von proteinen | |
| DE69734829D1 (de) | Infektiöse pseudovirale papillomavirus partikel | |
| DE60114018D1 (de) | Von zellen präsentierte peptide | |
| WO1999047639A3 (en) | Staphylococcus aureus genes and polypeptides | |
| ATE384263T1 (de) | Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen | |
| ES2141249T3 (es) | Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores. | |
| WO2002048403A3 (en) | Multiplexed protein expression and activity assay | |
| DK0960336T3 (da) | Peptidreagens til påvisning af humant cytomelagovirus (CMV) | |
| NO972063L (no) | Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle | |
| AU4908799A (en) | Determination of the hydrophobic pulmonary surfactant protein sp-c | |
| BR0010222A (pt) | Vetores de expressão viral | |
| ATE267253T1 (de) | Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung | |
| WO2002070691A3 (en) | Abcg4 transporter and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |